The finding of glutamate/glutamine abnormalities in a group of subjects at high genetic risk for schizophrenia lends support for both the glutamate dysfunction and neurodevelopmental hypotheses for schizophrenia.

This pilot study illustrates that children of individuals with schizophrenia feel their lives are impacted by their parent's illness. More research is needed in this area to quantify and describe the types of burden experienced by this vulnerable group to ensure availability of adequate support.

No abstract

No abstract